Kalveer Flora, MPharm, London North West University Healthcare National Health Service (NHS) Trust, discusses how she coordinates with providers on biosimilar switching programs.
In order to maintain sustainability and make sure that the switch goes well, what I like to do is organize regular catch-ups and touch base just to see how the homecare providers are doing in terms of switching.
What we do is, I usually switch patients in batches, so patients who have come to the clinic and have been told that they’ll be changing. I communicate this information to the homecare providers so that they know which patients they will be delivering the biosimilar to.
It’s important that homecare providers are aware, and also that they have enough medicines, because the last thing that I want is to switch a patient and there to be a problem with procuring the biosimilar for them. So it’s just really about organization and communication.